BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32567814)

  • 1. Large joint and lower extremity involvement have higher impact on disease outcomes in oligoarticular psoriatic arthritis.
    Ayan G; Solmaz D; Bakirci S; Tinazzi I; Omma A; Kucuksahin O; Ozisler C; Yavuz S; Bayindir O; Kimyon G; Dogru A; Tarhan EF; Can M; Kilic L; Duruoz MT; Aksu K; Kalyoncu U; Aydin SZ
    Int J Rheum Dis; 2020 Aug; 23(8):1094-1099. PubMed ID: 32567814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease.
    Coates LC; FitzGerald O; Gladman DD; McHugh N; Mease P; Strand V; Helliwell PS
    Arthritis Rheum; 2013 Jun; 65(6):1504-9. PubMed ID: 23529837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
    Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT;
    J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with patient-physician discordance in a prospective cohort of patients with psoriatic arthritis: An Asian perspective.
    Wang CTM; Kwan YH; Fong W; Xiong SQ; Leung YY
    Int J Rheum Dis; 2019 Jul; 22(7):1209-1215. PubMed ID: 30942553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study.
    Desthieux C; Granger B; Balanescu AR; Balint P; Braun J; Canete JD; Heiberg T; Helliwell PS; Kalyoncu U; Kvien TK; Kiltz U; Niedermayer D; Otsa K; Scrivo R; Smolen J; Stamm TA; Veale DJ; de Vlam K; de Wit M; Gossec L
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1606-1611. PubMed ID: 27998026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.
    Smolen JS; Schoels M; Aletaha D
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S48-50. PubMed ID: 26471734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.
    Kenar G; Yarkan H; Zengin B; Can G; Birlik M; Önen F
    Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.
    Cauli A; Gladman DD; Mathieu A; Olivieri I; Porru G; Tak PP; Sardu C; Scarpa R; Marchesoni A; Taylor WJ; Salvarani C; Kalden J; Lubrano E; Carneiro S; Piga M; Floris A; Desiati F; Flynn JA; D'Angelo S; van Kuijk AWR; Catanoso MG; Caso F; Contu P; Ujfalussy I; Helliwell PS; Mease PJ;
    J Rheumatol; 2018 Aug; 45(9):1256-1262. PubMed ID: 29907666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients.
    Eder L; Thavaneswaran A; Chandran V; Cook R; Gladman DD
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):264-72. PubMed ID: 25047020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
    Cauli A; Gladman DD; Mathieu A; Olivieri I; Porru G; Tak PP; Sardu C; Ujfalussy I; Scarpa R; Marchesoni A; Taylor WJ; Spadaro A; Fernàndez-Sueiro JL; Salvarani C; Kalden JR; Lubrano E; Carneiro S; Desiati F; Flynn JA; D'Angelo S; Vacca A; VAN Kuijk AW; Catanoso MG; Gruenke M; Peluso R; Parsons WJ; Ferrara N; Contu P; Helliwell PS; Mease PJ;
    J Rheumatol; 2011 May; 38(5):898-903. PubMed ID: 21324965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
    Kirkham B; de Vlam K; Li W; Boggs R; Mallbris L; Nab HW; Tarallo M
    Clin Exp Rheumatol; 2015; 33(1):11-9. PubMed ID: 25535650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient characteristics and minimal disease activity in psoriatic arthritis: a transcontinental comparison.
    Bakirci S; Ayan G; Gazel U; Tinazzi I; Solmaz D; Kasapoglu E; Kalyoncu U; Aydin SZ
    Clin Rheumatol; 2021 Aug; 40(8):3169-3174. PubMed ID: 33598808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?
    Michelsen B; Sexton J; Smolen JS; Aletaha D; Krogh NS; van der Heijde D; Kvien TK; Hetland ML
    Ann Rheum Dis; 2018 Dec; 77(12):1736-1741. PubMed ID: 30237203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
    Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and types of articular involvement in patients with psoriatic arthritis.
    Dönmez S; Pamuk ÖN; Akker M; Ak R
    Clin Rheumatol; 2015 Jun; 34(6):1091-6. PubMed ID: 25066919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis.
    Ayan G; Aydin SZ; Kimyon G; Ozisler C; Tinazzi I; Dogru A; Omma A; Kilic L; Yılmaz S; Kucuksahin O; Gönüllü E; Yıldız F; Can M; Balkarlı A; Solmaz D; Dalkılıc E; Bayindir O; Yıldırım Çetin G; Ergulu Esmen S; Ersozlu ED; Duruoz MT; Akyol L; Kucuk A; Bes C; Cınar M; Erden A; Mercan R; Bakirci S; Kasifoglu T; Yazısız V; Kalyoncu U
    Rheumatology (Oxford); 2021 Apr; 60(4):1755-1762. PubMed ID: 33097960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control.
    Furst DE; Tran M; Sullivan E; Pike J; Piercy J; Herrera V; Palmer JB
    Clin Rheumatol; 2017 Sep; 36(9):2045-2054. PubMed ID: 28238086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease burden measured by patient-reported outcomes: does psoriatic arthritis feel worse than rheumatoid arthritis? A cross-sectional nationwide study.
    Weman L; Salo H; Kuusalo L; Huhtakangas J; Vähäsalo P; Backström M; Kärki J; Sokka-Isler T
    Clin Exp Rheumatol; 2023 Nov; 41(11):2177-2181. PubMed ID: 37199149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.